Published Articles

1. Ryback SM, Hoogenboom HR, Meede HM, Raus JC, Schwartz D, Youle, R. Humanization of Immunotoxins. Proc Natl Acad Sci 89(8):3165-9, 1992.
2. Berliner JA, Schwartz D, Territo MC. Induction of Chemotactic Cytokines by Minimally Oxidized LDL. Adv Exp Med Biol 351:13-18, 1993.
3. Schwartz D, Andalibi A, Chaveri-Almada L, BerlinerJA. The Role of the Gro Family of Chemokines in Monocyte Adhesion to MM-LDL Stimulated Endothelium. J Clin Invest 94(5):1973-88, 1994.
4. Schwartz D, Billingsley K, Wallner KL. Follow-Up Care for Cancer—Making the Benefits Equal the Costs. Oncology 14(10):1493-1501, 2000.
5. Schwartz D, Schecter G, Seltzer S, Chauncy T. Radiation Myelitis Following Allogenic Stem Cell Transplantation and Consolidation Radiotherapy for Non-Hodgkin's Lymphoma. Bone Marrow Transplant 26(12):1355-1360, 2000.
6. Schwartz D, Billingsley K, Wallner K: Optimizing Cancer Follow-Up Care. Prim Care Cancer 21(1):27-34, 2001.
7. Schwartz D, Einck J, Bellon J, Laramore GE. Fast Neutron Radiotherapy for Soft Tissue and Cartilaginous Sarcomas at High Risk for Local Recurrence. Int J Radiat Oncol Biol Phys 50(2):449-56, 2001.
8. Billingsley K, Maynard C, Schwartz D, Dominitz J. The Use of Trimodality Therapy for the Treatment of Operable Esophageal Carcinoma in the Veteran Population: Patient Survival and Outcome Analysis. Cancer 92(5):1272-80, 2001.
9. Schwartz D, Einck J, Hunt K, Bruckner J, Conrad E, Koh WJ, Laramore GE. The Effect of Delayed Post-Operative Irradiation on Local Control of Soft Tissue Sarcomas of the Extremity and Torso. Int J Radiat Oncol Biol Phys 52(5):1352-9, 2002.
10. Billingsley K, Schwartz D, Lentz S. The Development of a Telemedical Cancer Center Within the Veterans Affairs Health Care System: A Report of Preliminary Clinical Results. Telemed J Educ Health 8(1):123-30, 2002.
11. Schwartz D, Barker J, Chansky K, Raminfar L, Yueh B, Dragos P, Cha C, Austin-Seymour M, Laramore GE, Hillel A, Weymuller EA, Wallner K. Post-Treatment Surveillance for Squamous Cell Carcinoma of the Head and Neck—Too Much for Too Little? Head Neck25:990-99, 2003.
12. Schwartz D, Rajendran J, Yueh B, Coltrera M, Anzai Y, Eary J, Krohn K. Staging of Head and Neck Squamous Cell Cancer with Extended-Field FDG-PET Arch Otolaryngol Head Neck Surg 129:1173-1178, 2003.
13. Rajendran J, Mankoff D,O’Sullivan F, Peterson L, Schwartz D, Conrad E,Spence A, Muzi M, Farwell G, Krohn K. Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by FMISO and FDG-PET Imaging. Clin Cancer Res 10:2245-2252, 2004.
14. Choi S, Schwartz D, Farwell DG, Austin-Seymour M, Futran N. Radiotherapy Does Not Impact Local Complication Rates Following Free Flap Reconstruction for Head and Neck Cancer Arch Otolaryngol Head Neck Surg 130:1308-1312, 2004.
15. Schwartz D, Rajendran J, Yueh B, Coltrera M, LeBlanc M, Eary J, Krohn K. FDG-PET Prediction of Head and Neck Squamous Cell Cancer Outcomes. Archives of Otolaryngol Head Neck Surg 130:1361-1367, 2004.
16. Schwartz D, Ford E, Rajendran J, Yueh B, Coltrera M, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Kinahan P, Meyer J, Phillips M, LeBlanc M, Krohn K, Eary J, Laramore G. FDG-PET/CT Imaging for Pre-Radiotherapy Staging of Head and Neck Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys 61(1):129-136, 2005.
17. Schwartz D, Ford E, Rajendran J, Yueh B, Coltrera M, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Kinahan P, Meyer J, Phillips M, LeBlanc M, Krohn K, Eary J, Laramore G. FDG-PET/CT-Guided Intensity Modulated Head and Neck Radiotherapy: A Pilot Investigation. Head Neck 27:478-87, 2005.
18. Schwartz D, Montgomery RB, Yueh B, Donahue M, Anzai Y, Canby R, Buelna R, Anderson L, Boyd C, Hutson J, Keegan K. Phase I and Initial Phase II Results from a Trial Investigating Weekly Docetaxel and Carboplatin Given Neoadjuvantly and Then Concurrently with Concomitant Boost Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Cancer 10:2543-34, 2005.
19. Rajendran JG, Schwartz DL, O’Sullivan J, Peterson LM, Ng P, Scharnhorst J, Grierson JR, Krohn KA. Tumor hypoxia imaging with (F-18) fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 12:5435-5441, 2006.
20. Ford E, Kinahan P, Hanlon L, Alessio A, Rajendran J, Schwartz D, Phillips M. Tumor delineation using FDG-PET and FMISO-PET in Head and Neck and Lung Cancers: Threshold Contouring and Lesion Volumes. Med Phys 33:4280-88, 2006.
21. O’Daniel J, Rosenthal D, Garden A, Barker J, Ahamad A, Ang K, Asper J, Blanco A, de Crevoisier R, Holsinger F, Patel C, Schwartz D, Wang H, Dong L. The Effect of Dental Artifacts, Contrast Media, and Experience on Intraobserver Contouring Variations in Head and Neck Anatomy. Am J Clin Onol, 30:191-98, 2007.
22. O’Daniel J, Garden A, Schwartz D, Wang H, Ang KK, Ahamad A, Rosenthal D, Morrison W, Asper J, Zhang L, Tung S, Mohan R, Dong L. Parotid gland dose in head-and-neck intensity-modulated radiotherapy: Is what you plan what you get? Int J Radiat Oncol Biol Phys, 69(4):1290-96, 2007.
23. Diagaradjane P, Orenstein-Cardona JM, E Colón-Casasnovas N, Deorukhkar A, Shentu S, Kuno N, Schwartz D, Gelovani JG, Krishnan S. Imaging Epidermal Growth Factor Receptor Expression In Vivo: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe. Clin Cancer Res 14:731-41,2008.
24. Petsuksiri J, Frank S, Ahamad A, Chao KSC, Morrison WH, Rosenthal DI, Schwartz D, Garden AS, Ang KK: Radiation Outcomes for Squamous Cell Carcinoma of the Eyelid—Long-Term Update of the M.D. Anderson Experience, Cancer, 112(1):111-118, 2008.
25. Allen M, Schwartz D, Rana V, Adapala P, Morrison W, Hanna E, Weber R, Garden A, Ang KK. Long term radiotherapy outcomes for nasal cavity and septal cancers Int J Radiat Oncol Biol Phys 71:401-6, 2008.
26. Dobie S, Warren J, Matthews B, Schwartz D, Billingsley K, Baldwin L. Survival Benefits and Trends in Use of Adjuvant Therapy Among Elderly Stage II and III Rectal Cancer Patients in the General Population Cancer 112:789-99, 2008.
27. Li H, Zhu XR, Zhang L, Dong L, Tung S, Ahamad A, Chao KS, Morrison WH, Rosenthal DI, Schwartz D, Mohan R, Garden AS. Comparison of 2D Radiographic Images and 3D Cone Beam Computed Tomography for Positioning Head-and-Neck Radiotherapy Patients. Int J Radiat Oncol Biol Phys 71:916-25, 2008.
28. Schwartz D, Rana V, Shaw S, Yazbeck C, Ang K, Garden A, Morrison W, Rosenthal D, Hoff A, Evans D, Clayman G, Sherman. Radiotherapy For Advanced Medullary Thryoid Cancer - Local Disease Control Results in the Modern Era. Head Neck 7:883-8 [2008].
29. Sulman E, Schwartz D, Morrison W,Rosenthal D, Ahamad A, Chao K, Ang KK, Garden A, IMRT Re-Irradiation for Locoregionally Recurrent or In-Field Second Primary Head and Neck Cancer. Int J Radiat Oncol Biol Phys 73(2):399-409 [2009].
30. Ihle N, Lemos R, Schwartz D, Oh J, Halter R, Wipf P, Kirkpatrick L, Powis G. The PPARγ agonist pioglitazone prevents the increase in bloodglucose caused by phosphoinositide-3-kinase pathway inhibitionwithout blocking antitumor activity. Mol Cancer Ther 8(1):94-100 [2009].
31. Schwartz D, Lobo MJ, Ang KK, Morrison WH, Rosenthal DI, Evans DB, Clayman G, Sherman SI, Garden AS. Post-Operative External Beam Radiotherapy for Differentiated Thyroid Cancer—Outcomes and Morbidity with Conformal Treatment. Int J Radiat Oncol Biol Phys  In Press.
32. MoellerBJ, RanaV, CannonBA, Williams MD, SturgisEM, GinsbergLF, Macapinlac HA, AngKK, ChaoK, ChronowskiGM, FrankSJ, MorrisonWH, RosenthalDI, GardenAS, Lippman S, SchwartzD. Risk-Adjusted FDG-PET/CT Assessment of Radiotherapy Response in Head and Neck Cancer—A Prospective Evaluation. J Clin Oncol In Press.
33. Schwartz D, Thitai-Kumar A, Williams R, He Y, Lemos R, Bankston J, Jackson E, Volgin A, Soghomonyan S, Mushkudiani I, Yeh HH, Nishii R, Mukhopadhay U, Alauddin M, Bornman W, Gelovani J, Powis G. The Selective HIF-1 Inhibitor PX-478 Provides In Vivo Radiosensitization Through Tumor Stromal Effects. Mol Cancer Ther In Press.
34. Smith GL, Smith BD, Garden AS, Rosenthal DI, Sherman SI, Morrison WH, Schwartz D, Weber R, Ang KK, Buchholz TA. Hypothyroidism in Older Head and Neck Cancer Patients After Treatment with Radiation: A Population-Based Study. Head Neck In Press.
35. Bhatia A, Rao A, Ang KK, Garden AS, Morrison WH, Rosenthal DI, Evans DB, Clayman G, Sherman SI, Schwartz D. Anaplastic Thyroid Cancer—Clinical Outcomes with Conformal Radiotherapy. Int J Radiat Oncol Biol Phys In Press.
36. Schwartz D, Thitai-Kumar A, Oh J, Williams R, He Y, Lemos R, Bankston J, Jackson E, Volgin A, Soghomonyan S, Mushkudiani I, Yeh HH, Nishii R, Mukhopadhay U, Alauddin M, Kuno N, Krishnan S, Bornman W, Powis G, Gelovani J. Imaging Biomarker Assessment of Tumor Adaptation to Radiation-Induced Ischemia. Submitted.
37. Yildirim G, Morrison WH, Holsinger FC, Rosenthal DI, Sturgis EM, Schwartz D, Garden AS. Outcomes of Patients with Tonsillar Carcinoma Treated with Post-Tonsillectomy Radiation Therapy. Submitted.
38. Rosenthal DI, Fuller CD, Barker JL, Mason B, Garcia J, Lewin JS, Holsinger FC, Stasney CR, Frank SJ, Schwartz D, Morrison WH, Garden AS, Ang KK. Simple Carotid-Sparing IMRT Technique and Preliminary Results for T1-2 Glottic Cancer. Submitted.
39. Thitai-Kumar A, Bankston J, He Y, Lemos R, Hazle J, Powis G, Gelovani J, Schwartz D. Validation of Co-Registered Vascular MRI and Ultrasound Biomicroscopy in a Preclinical Tumor Window Imaging Platform. Submitted.
40. Schwartz D, Hutcheson K, Barringer D, Tucker SL, Kies M, Ang KK, Morrison WH, Rosenthal DI, Garden AS, Dong L, Lewin JS. Dosimetric Predictors for Long Term Dysphagia Following Oropharyngeal IMRT. Submitted.
41. Thitai-Kumar A, Bankston J, He Y, Lemos R, Hazle J, Powis G, Gelovani J, Schwartz D. Combined Vascular MRI and Ultrasound Imaging of Early Tumor Stromal Adaptive Responses to Radiation.  In Preparation.
42. Schwartz D, Thitai-Kumar A, Williams R, He Y, Lemos R, Bankston J, Jackson E, Gelovani J, Powis G. Image-Guided Preclinical Sequencing of the Selective HIF-1 Inhibitor PX-478 with Radiation. In Preparation.
43. Moeller BJ, RanaV, CannonBA, GinsbergLF, Macapinlac HA, AngKK, ChaoK, ChronowskiGM, FrankSJ, MorrisonWH, RosenthalDI, GardenAS, Lippman S, SchwartzD. Prospective Evaluation of FDG-PET/CT as a Quantitative Imaging Biomarker for Head and Neck Cancer Treatment Outcome. In Preparation.
44. Schwartz D, Garden AS, Tung S, Wong P, Garcia J, Zhang Y, Zhang L, Dong L. Adaptive Radiotherapy for Head and Neck Cancer—Dosimetric Results from a Prospective Trial. In Preparation.
• Yuan Q, Zhang Y, Jackson EF, Dong L, Schwartz D. Early Vascular MRI Assessment of Tumor Response to Head and Neck Radiotherapy. In Preparation.

Invited Articles

1. Chambers M, Garden A, Rosenthal D, Ahamad A, Schwartz D, Blanco A, Chao KSC, Morrison W, Ang KK, Weber R. Intensity Modulated Radiotherapy: Is Xerostomia Still Prevalent? Curr Oncol Rep 7:131-136, 2005.
2. Frank S, Chao K, Schwartz D, Weber R, Apisarntharnarx S, Macapinlac H. The Utilization of PET and PET/CT in Head and Neck Tumor Staging and Radiation Therapy Treatment Planning. Nat Clin Pract Oncol 2 10:526-533, 2005.
3. Schwartz D, Garden A. Head and Neck Radiotherapy-Current Progress and Future Directions. Hematol Oncol Clin North Am 20:239-259, 2006.

Abstracts

1. Schwartz, D., Olsen, P., Andalibi, A., and Berliner, J.A.   The Role of MGSA-Gro Homologues in Endothelial-Monocyte Interactions. VII International Endothelial Cell Biology Conference, 1993.
2. Schwartz, D., Bellon, J., and Laramore, G.E. Fast Neutron Radiotherapy for High Risk Sarcomas: An Update of the University of Washington Experience. Annual meeting of the Radiological Society of North America, 2000.
3. Billingsley, K., Schwartz, D., and Dominitz, J. National VA Survival Statistics for Esophageal Cancer Following Surgery or Trimodality Therapy. Annual meeting of the Society of Surgical Oncology, 2001.
4. Schwartz, D., Einck J., Hunt, K, Bruckner, J., Conrad, E., Koh W.-J., and Laramore, G.E. The Impact of Delayed Post-Operative Radiotherapy on Multimodality Therapy Outcomes for Soft Tissue Sarcoma of the Extremity and Torso. Annual meeting of the American Society of Therapeutic Radiology and Oncology, 2001.
5. Barker, J., Schwartz, D., Raminfar, L., Dragos, P., Cha, C., Yueh, B., and Wallner, K. Post-Treatment Surveillance for Squamous Cell Carcinoma of the Head and Neck—Too Much Cost for Too Little Gain? Annual meeting of the American Society of Therapeutic Radiology and Oncology, 2001.
6. Schwartz, D., Mattes, D., Rajendran, J., Kinahan, P., Haynor, D., Lewellen, T., Krohn, K, and Eary, J. Head and Neck PET/CT Fusion Using a Non-Rigid Image Registration Algorithm—Validation Results. Annual meeting of the Society of Nuclear Medicine, 2002.
7. Rajendran, J., Peterson, L.,Schwartz, D.,Muzi, M., Scharnhorst, J., Eary, J.and Krohn, K. [F-18] MISO-PET Hypoxia Imaging in Head and Neck Cancer: Heterogeneity in Hypoxia--Primary Tumor vs Lymph Nodal Metastases. Annual meeting of the American Association of Cancer Research, 2002.
8. Rajendran, J., Muzi, M., Peterson, L., Diaz, A., Schwartz, D., Spence, A., and Krohn, K. [18-F] MISO-PET Tumor Hypoxia Images: What is the Best Method to Express the Extent of Hypoxia? Annual meeting of the Society of Nuclear Medicine, Los Angeles, CA, 2002.
9. Schwartz, D., Meyer, J., Rajendran, J., Yueh, B., Mattes, D., Haynor, D., Phillips, M., Kinahan, P, and K.A. Krohn. Registered FDG-PET/CT Imaging to Direct Head and Neck Radiotherapy. American Head and Neck Society Research Workshop, Washington, D.C., 2002.
10. Rajendran, J., Peterson, L.,Schwartz, D.,Muzi, M., Scharnhorst, J., Eary, J.and Krohn, K. Head and Neck Intensity Modulated Radiotherapy Directed by [F-18] MISO-PET Hypoxia Imaging. American Head and Neck Society Research Workshop, Washington, D.C., 2002.
11. Rajendran J,O’Sullivan F, Peterson L, O’Sullivan J, Muzi M, Schwartz D,Conrad E, Krohn K: Heterogeneity Measure in Tumor Hypoxia: A Novel Way to Characterize [F-18] MISO-PET Hypoxia Imaging. Annual meeting of the American Association of Cancer Research, Toronto, CA, 2003.
12. Schwartz D, Yueh B, Montgomery RB, Donahue M, Hutson J, Back A, Anzai Y, Canby R, Anderson L, Boyd C: A Phase I/II Trial Investigating Weekly Docetaxel and Carboplatin Given Neoadjuvantly and Then Concurrently with Concomitant Boost Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Annual meeting of the American Society of Clinical Oncology, Chicago, IL, 2003.
13. Rajendran J,O’Sullivan F, Peterson L,O’Sullivan J, Schwartz D,Muzi M, Grierson J, Krohn K: Heterogeneity Measure of Tumor Hypoxia and Metabolism in Head and Neck Cancer: FMISO and FDG-PET as Molecular Probes. Annual meeting of the Society of Nuclear Medicine, New Orleans, LA, 2003.
14. Rajendran J, Meyer J,Schwartz D, Kinahan P, Cheng P, Hummel S, Lewellen B, Phillips M, Krohn K: Imaging with [F-18] FMISO-PET Permits Hypoxia-Directed Radiotherapy Dose Escalation For Head And Neck Cancer. Annual meeting of the Society of Nuclear Medicine, New Orleans, LA, 2003.
15. Ng, P., Rajendran, J., Schwartz, D., Patterson, L., Scharnhorst, J., Krohn, K. Can [F-18] Fluoromisonidazole PET Imaging Predict Treatment Response in Head and Neck Cancer? Annual meeting of the Society of Nuclear Medicine, New Orleans, LA, 2003.
16. Rajendran J, Ng P, Peterson L, Schwartz D, Scharnhorst J, Conrad E, Grierson J, Krohn K: F-18 FMISO-PET Tumor Hypoxia Imaging: Investigating the Tumor Volume-Hypoxia Connection. Annual meeting of the Society of Nuclear Medicine, New Orleans, LA, 2003.
17. Meyer J, Ford EC, Kinahan P, Lewellen B, Rajendran J, Schwartz D, Phillips MH: Deformable Image Registration for IMRT of Head and Neck Cancer. Annual meeting of the American Association of Physicists in Medicine, San Diego, CA, 2003.
18. Schwartz D, Ford E, Meyer J, Rajendran J, Yueh B, Coltrera M, Anzai Y, Lewellen B, Virgin J, Kinahan P, Phillips M, Krohn K: Combined FDG-PET/CT Imaging for Staging and IMRT Treatment Planning for Squamous Cell Carcinoma of the Head and Neck. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Salt Lake City, UT, 2003.
19. Choi S, Schwartz D, Farwell DG, Futran N, Austin-Seymour M, Laramore GE, Weymueller E: Radiotherapy Does Not Impact Complication Rates Following Free Flap Reconstructive Surgery for Head and Neck Cancer. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Salt Lake City, UT, 2003.
20. Rajendran J, Schwartz D, O’Sullivan F, Ng P, Peterson L, Scharnhorst J, Grierson J, Krohn K: Tumor Hypoxia Imaging with [F-18] FMISO-PET in Head and Neck Cancer: Ability of Pre-therapy FMISO Uptake in Predicting Survival. Annual meeting of the Radiological Society of North America, Chicago, IL, 2003.
21. Rajendran J, Schwartz D, O’Sullivan F, Ng P, Peterson L, Krohn K: Hypoxia Guided Treatment Selection: The Rationale for Using [F-18] FMISO-PET in Identifying and Quantifying Hypoxia in Head and Neck Cancer. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, MA, 2003.
22. Schwartz, D., Yueh, B., Montgomery, R.B., Donahue, M., Canby, R., Anzai, Y., Buelna, R., Anderson L, Keegan K, Boyd C: A Phase I/II Trial Investigating Weekly Docetaxel and Carboplatin Given Neoadjuvantly and Then Concurrently with Concomitant Boost Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Annual meeting of the American Society of Clinical Oncology, New Orleans, LA, 2004.
23. Schwartz D, Buelna R, Ford E, Yockey K, Schulte S, Miller R, LeBlanc M, Yueh B: Novel Dose-Limiting Structures for Head and Neck Radiotherapy Planning. 6th International Conference on Head and Neck Cancer, Washington, D.C., 2004.
24. Schwartz D, Yueh B, Montgomery RB, Donahue M, Canby R, Anzai Y, Buelna R, Anderson L, Keegan K, Boyd C: Induction and Concurrent Docetaxel/Carboplatin with Radiotherapy for Locally Advanced Head and Neck Cancer. 6th International Conference on Head and Neck Cancer, Washington, D.C., 2004.
25. Ford E, Schwartz D, Rajendran J, Yueh B, Coltrera M, Anzai Y, Lewellen B, Virgin J, Krohn K, Laramore G: FDG-PET/CT-Directed Head and Neck IMRT Dose Escalation. 6th International Conference on Head and Neck Cancer, Washington, D.C., 2004.
26. Krishnan S, Shentu S, Schwartz D, Puduvalli V: Suberoyl anilide hyroxamic acid (SAHA) sensitizes pancreatic cancer cells to radiation therapy. Submitted to the Annual meeting of the American Society of Therapeutic Radiology and Oncology, Denver, CO, 2005.
27. Wu TH, Zhu X, Lai PA, Wong PF, Tung S, Mason B, Garden A, Rosenthal D, Morrison W, Ahamad A, Schwartz D, Chiou JF, Huang KW, Yen CY, Chao K: A planning technique for intensity modulated therapy of head and neck cancers. Submitted to the Annual meeting of the American Society of Therapeutic Radiology and Oncology, Denver, CO, 2005.
28. O’Daniel J, Rosenthal D, Barker J Jr., Ahamad A, Asper JA, Blanco AI, de Crevoisier R, Holsinger FC, Schwartz D, Ang KK, Dong L, Garden AS Inter-observer Contouring Variations of Head-and-Neck Anatomy. Submitted to the Annual meeting of the American Society of Therapeutic Radiology and Oncology, Denver, CO, 2005.
29. Arafat W, Schwartz D, Rosenthal D, Ahamad A, Morrison W, Chao K, Garden A, Ang KK: Adjuvant IMRT for Esthesioneuroblastoma—The Early M.D. Anderson Experience. European Cancer Conference (ECCO13), Paris, France, 2005.
30. Allen M, Schwartz D, Rosenthal D, Ahamad A, Morrison W, Chao K, Garden A, Ang KK: Radiation Outcomes for Nasal Cavity Squamous Cell Carcinoma—Long-Term Update of the M.D. Anderson Experience. Annual meeting of the American Radium Society, Maui, HI, 2006.
31. Schwartz D, Krishnan S, Kuno N, Mushkudiani I, Volgin A, Yeh HH, ,He Y, Soghomonyan S, Shentu S, Powis G, Gelovani J: Molecular-Genetic Imaging of HIF-1 Signaling Response to Radiation and Targeted Inhibition. Annual meeting of the Society for Molecular Imaging, Hawaii, HI, 2006.
32. Sulman E, Schwartz D, Morrison W, Rosenthal D, Ahamad A, Chao K, Ang KK, Garden A: IMRT Re-Irradiation for Locoregionally Recurrent or In-Field Second Primary Head and Neck Cancer. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
33. Schwartz D, Krishnan S, Kuno N, Mushkudiani I, Volgin A, Yeh HH, He Y, Soghomonyan S, Shentu S, Powis G, Gelovani J: Molecular-Genetic Imaging of In Vitro and In Vivo HIF-1 Signaling Response to Radiation. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
34. Li H, Zhu XR, Zhang L, Dong L, Ahamad A, Chao KSC, Morrison WH, Rosenthal DI, Schwartz D, Garden AS: Assessment of Positioning Accuracy of Head and Neck Patients Receiving IMRT Using On-Board Imaging and Cone Beam CT. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
35. Frank S, Ahamad A, Chao KSC, Morrison WH, Rosenthal DI, Schwartz D, Garden AS, Ang KK: Radiation Outcomes for Squamous Cell Carcinoma of the Eyelid—Long-Term Update of the M.D. Anderson Experience. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Philadelphia, PA, 2006.
36. Schwartz D, Krishnan S, Kuno N, Mushkudiani I, Volgin A, Yeh H-H, He Y, Soghomonyan S, Shentu S, Powis G, Gelovani J: Molecular-Genetic Imaging of In Vitro and In Vivo HIF-1 Signaling Response to Radiation. Annual meeting of the Radiological Society of North America, Chicago, IL, 2006.
37. Schwartz D, Oh J, Williams R, He Y, Lemos R, Kuno N, Krishnan S, Volgin A, Soghomonyan S, Nishii R, Alauddin M, Mukhopadhay U, Bornmann W, Jackson E, Powis G, Gelovani J. Spatiotemporal Imaging of HIF-1 Mediated Tumor Cell-Stromal Adaptation to Hypoxia Following Radiation. 13th International Congress of Radiation Research, San Francisco, CA, 2007.
38. Cannon B, Schwartz D, Dong L. Assessment of Therapy-Induced Changes of Head and Neck Cancers Using 18F-FDG PET/CT Imaging Studies Performed Prior to Interest Based (ROI) Analysis. Annual Meeting of the American Association of Physicists in Medicine, Minneapolis, MN, 2007.
39. Schwartz D, Oh J, Williams R, He Y, Lemos R, Kuno N, Volgin A, Soghomonyan S, Nishii R, Alauddin M, Mukhopadhay U, Bornmann W, Jackson E, Powis G, Gelovani J. Molecular-Genetic Image-Guided Sequencing of Radiotherapy with Targeted HIF-1 Inhibition. Joint Molecular Imaging Conference, Providence, RI, 2007.
40. Shaw S, Yazbeck C, Rana V, Ang K, Garden A, Morrison W, Rosenthal D, Hoff A, Evans D, Clayman G, Sherman, Schwartz D. Radiotherapy for Advanced Medullary Thyroid Cancer—Local Disease Control Results in the Modern Era.  Annual meeting of the American Society of Therapeutic Radiology and Oncology, Los Angeles, CA, 2007.
41. Cannon B, Schwartz D, Dong L. Assessment of Therapy-Induced Changes of Head and Neck Cancers Using 18F-FDG PET/CT Imaging Interest Based (ROI) Analysis. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Los Angeles, CA, 2007.
42. Yildirim G, Morrison W, Holsinger C, Rosenthal D, Sturgis E, Schwartz D, Garden A. Outcome of Patients with Tonsillar Carcinoma Treated with Post-tonsillectomy Radiation Therapy. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Los Angeles, CA, 2007.
43. Schwartz D, Oh J, Williams R, He Y, Lemos R, Kuno N, Volgin A, Soghomonyan S, Nishii R, Alauddin M, Mukhopadhay U, Bornmann W, Jackson E, Gelovani J, and Powis G. Molecular-Genetic Image Guided Studies of the Antitumor HIF-1α Inhibitor PX-478 in Combination with Radiation. Annual meeting of the American Association of Cancer Research, San Diego, CA, 2008.
44. Schwartz D, Dong L, Jackson E, and Garden A. Pilot Clinical Experience with Image-Guided Adaptive Radiotherapy for Head and Neck Cancer. 7th International Conference on Head and Neck Cancer, San Francisco, CA, 2008.
45. Moeller B, Cannon B, Rana V, Ang KK, Chao C, Chronowski G, Frank S, Garden A, Morrison W, Rosenthal D, Dong L, and Schwartz D. FDG-PET/CT Imaging Does Not Impact Post-Radiation Response Assessment for Advanced Head and Neck Cancer. 7th International Conference on Head and Neck Cancer, San Francisco, CA, 2008.
46. Lobo M, Garden A, Morrison W, Ang KK, Rosenthal D, Chao C, Evans D, Clayman G, Sherman S, and Schwartz D. Intensity Modulated Radiotherapy for Differentiated Thyroid Cancer. 7th International Conference on Head and Neck Cancer, San Francisco, CA, 2008,
47. Schwartz D, GardenAS, Tung S, Wong P, GarciaJ, ZhangY, ZhangL, and DongL.  Clinical Experience with In-Room CT-Guided Adaptive Radiotherapy for Head and Neck Cancer. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 2008.
48. Lewin J, Hutcheson K, Barringer D, Tucker S, Rosenthal DI, Chao C, Morrison W, Gardern AS, Dong L, and Schwartz, D. Dosimetric Predictors of Long-Term Dysphagia Following Oropharyngeal IMRT. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 2008.
49. Moeller BJ, Cannon B, Ang KK, Chao C, Chronowski G, Frank S, Morrison W, Rosenthal DI, Garden AS, and Schwartz D. Does FDG-PET/CT Provide Added Value Over CT Alone for Assessment of Radiation Response in Advanced Stage Head and Neck Cancer? Annual meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 2008.
50. Yuan Q, Zhang Y, Jackson E, Garden AS, Dong L, and Schwartz D. Early MRI Assessment of Treatment Response to Head and Neck Radiotherapy.  Annual meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 2008.
51. Volgin A, LeRoux L, Maxwell D, Schellingerhout D, Titai-Kumar A, He Y, Gelovani J, and Schwartz D. In Vitro 3D Modeling of Host Organ-Specific Whole Tumor Responses to Radiation. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 2008.
52. Lobo M, Garden AS, Morrison W, Ang KK, Rosenthal DI, Chao C, Evans DB, Clayman G, Sherman S, and Schwartz D. Post-Operative External Beam Radiotherapy for Differentiated Thyroid Cancer—Modern Era Outcomes and Morbidity. Annual meeting of the American Society of Therapeutic Radiology and Oncology, Boston, MA, 2008.
53. Volgin A, LeRoux L, Maxwell D, Schellingerhout D, Titai-Kumar A, He Y, Gelovani J, and Schwartz D. 3D Modeling of Host Organ-Specific Whole Tumor Responses to Radiation. World Molecular Imaging Congress, Nice, France, 2008.
54. Thitai-Kumar A, Hazel J, Gelovani J, Bankson J, and Schwartz, D. Registered MRI-US Platform for Preclinical Imaging—A Feasibility Study. World Molecular Imaging Congress, Nice, France, 2008.
55. Schwartz D, GardenAS, Tung S, Wong P, GarciaJ, ZhangY, ZhangL, and DongL. Dosimetric Improvements with Image-Guided Adaptive Radiotherapy for Head and Neck Cancer. Annual meeting of the American Radium Society, Vancouver, BC, 2009.
56. Schwartz D, Hutcheson K, Barringer D, Tucker S, Rosenthal DI, Chao C, Morrison W, Gardern AS, Dong L, and Lewin J. Dosimetric Predictors of Long-Term Dysphagia Following Oropharyngeal IMRT. Combined Otolaryngology Spring Meetings, Phoenix, AZ, 2009.

Book Chapters

1. Einck J, Schwartz D. Radiation Therapy for Malignant Soft Tissue Tumors. In: Orthopedic Knowledge Update, American Academy of Orthopedic Surgeons, 2001.
2. Schwartz, D. The Current Role of FDG-PET/CT Imaging in 2008 Oncologic Practice. American Association of Physicists in Medicine, 2008 Summer School Syllabus.
3. Schwartz D, Lee S, Ang KK: The Orbit, In: Radiation Oncology, 9th Edition, Eds. Cox JD, Ang KK. Mosby, St. Louis, MO, In Press.
4. Kupferman ME, Sturgis ES, Schwartz DL, Garden AS, Kies MS: Neoplasms of the Head and Neck, In“ Cancer Medicine, 7th Edition, Eds. Holland JF, Frei E, BC Decker, Hamilton, ON, In Press.